¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Nail cross furrows"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nail pits
    ¼Õ¹ßÅé¿À¸ñ
  • nail root
    ¼Õ¹ßÅé»Ñ¸®, Á¶°©±Ù
  • nail wall
    ¼Õ¹ßÅ鼺°û
  • spoon nail
    ¼ù°¡¶ô¼Õ¹ßÅé
  • shell nail
    Á¶°³¼Õ¹ßÅé
  • blue cross
    û½ÊÀÚ
  • criss-cross inheritance
    ½ÊÀÚÀ¯Àü, À̼ºÀ¯Àü
  • cross
    ±³Â÷
  • cross absorption
    ±³Â÷Èí¼ö
  • cross birth
    ȾÀ§ºÐ¸¸
  • cross bridge
    ±³Â÷°áÇÕ, ¿¬°á´Ù¸®
  • cross bridge cycle
    ±³Â÷°áÇÕÁÖ±â
  • cross circulation
    ±³Â÷¼øÈ¯
  • cross cylinder
    ±³Â÷¿øÁÖ·»Áî
  • cross fertilization
    ±³Â÷¼öÁ¤, Ÿ°¡¼öÁ¤
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nail matrix
    ¼Õ¹ßÅé¹ÙÅÁÁú
  • nail
    ¼Õ¹ßÅé, ¸ø
  • nail hypertrophy onychauxis
    ¼Õ¹ßÅéºñ´ë
  • nail incurvatum
    ¼Õ¹ßÅé¾È±ÁÀ½
  • nail root
    ¼ÕÅé»Ñ¸®
  • nail splitting
    (¢¡onychorrhexis) ¼Õ¹ßÅé¼¼·Î°¥¸²
  • nail wall
    ¼ÕÅ鼺°û, ¹ßÅ鼺°û
  • reedy nail
    ¼ÕÅéÁ¾¿­Áõ, °¥´ë¼ÕÅé
  • shell nail
    Á¶°³¼Õ¹ßÅé
  • spoon nail
    ¼ù°¡¶ô¼ÕÅé
  • terry nail
    µÎÅÍ¿î¹ßÅé
  • toe nail
    ¹ßÅé
  • triangular nail
    »ïÀͰíÁ¤¸ø
  • turtle-back nail
    °ÅºÏµî¼ÕÅé
  • cross absorption
    ±³Â÷Èí¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fracutre nail
    °ñÀý Á¤, °ñÀý°íÁ¤Á¤(Íéï¹Í³ïÒïù).
  • fragile nail
    Ãë¾à¼Õ¹ßÅé
  • fragilitas unguium = brittle nail
    ¼Õ¹ßÅéÃë¾àÁõ, Á¶°©Ãë¾àÁõ
  • green nail
    ³ì»ö ¼Õ¹ßÅé
  • green nail syndrome
    ³ì»ö ¼Õ¹ßÅé ÁõÈıº
  • half and half nail
    ¹Ý¹Ý Á¶°©
  • ingrowing nail
    Á¶°©°¨ÀÔ(Áõ), ³»½Å¼º ¼Õ¹ßÅé
  • racquet nail
    ¶óÄÏÇü ¼Õ¹ßÅé
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • half and half nail
    ¹Ý¹Ý Á¶°©
  • hippocratic nail
  • ingrowing nail
    Á¶°©°¨ÀÔ(Áõ), ³»½Å¼º ¼Õ¹ßÅé
  • intramedullary nail
    °ñ¼ö³» Á¤(ÍéâÐÒ®ïù), °ñ¼ö³» ¸ø, °ñ¼ö³» ±Ý¼ÓÁ¤<¼ö³»Á¤(âÐÒ®ïù)>.
  • koilonychia = spoon nail
    ½Ã»óÁ¶°©,½ºÇ¬ÇüÁ¶°©,¼ù°¡¶ô¼Õ¹ßÅé
  • median nail dystrophy
    Á¤Áß¼Õ¹ßÅéÀÌ¿µ¾ç(Áõ)
  • nail
    ¼ÕÅé, Á¶(°©)(ðÐ).
  • nail
    ¹ßÅé
  • nail
    ¼ÕÅé
  • nail
    ¼ÕÅé
  • nail
    ¼ÕÅé,Á¶(°©)(ðÐ)
  • nail bed
    ¹Ù´Ú
  • nail bed ³ª matrix unguis
    ¼ÕÅé¹Ù´Ú, Á¶»ó(ðÐßÉ).
  • nail bed ³ª matrix unguis
    ¼ÕÅé¹Ù´Ú,Á¶»ó
  • nail bite
    ¼Õ¹ßÅé¹°À½
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Base of nail
    ¼ÕÅé¹Ù´Ú
    [¿¾ ¿ë¾î] Á¶±âÀú
  • Nail matrix
    ¼ÕÅé¹ÙÅÁÁú
    [¿¾ ¿ë¾î] Á¶±âÁú
  • Nail matrix
    ¼ÕÅé¹ÙÅÁÁú
    [¿¾ ¿ë¾î] Á¶»ó
  • Nail root
    ¼ÕÅé»Ñ¸®
    [¿¾ ¿ë¾î] Á¶±Ù
  • Nail wall
    ¼ÕÅ鼺°û
    [¿¾ ¿ë¾î] Á¶°û
  • Nail fold
    ¼ÕÅéÁÖ¸§
    [¿¾ ¿ë¾î] Á¶ÁÖ¸§
  • Nail plate
    ¼ÕÅéÆÇ
    [¿¾ ¿ë¾î] Á¶ÆÇ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀ Ç׿ø(Îßó©Úãëëù÷ê«)
  • cross-reacting material
    ±³Â÷¹ÝÀÀ ¹°Áú(Îßó©ÚãëëÚªòõ)
  • cross-reaction
    ±³Â÷¹ÝÀÀ(Îßó©Úãëë)
  • cross-reactivation
    ±³Â÷ÀçȰ¼ºÈ­(Îßó©î¢üÀàõûù)
  • cross-resistance
    ±³Â÷ÀúÇ×(Îßó©î½ù÷)
  • cross-sensitization
    ±³Â÷°¨ÀÛ(Îßó©ÊïíÂ)
  • cross-term diffusion coefficient
    ¹æÇØ È®»ê°è¼ö(Ûªúªüªß¤Íªâ¦)
  • cross tolerance
    ±³Â÷³»¼º(Îßó©Ò±àõ)
  • genetic cross
    À¯Àü ±³Â÷(ë¶îîÎßó©)
  • helical cross
    ³ª¼± ½ÊÀÚ(Õ¢àÁä¨í®)
  • phage cross
    ÆäÀÌÁö ±³Â÷(Îßó©)
  • photoactivated cross-linking
    ±¤ºÎȰ ±³Â÷ ¿¬°á(ÎÃÝ¥üÀÎßó©Ö§Ì¿)
  • three-factor cross
    »ïÀÎÀÚ ±³Â÷ (ß²ì×í­Îßó©)
  • three-point cross
    ¼¼Á¡ ±³Â÷(Îßó©)
  • two-factor cross
    ÀÌÀÎÀÚ ±³Â÷(ì£ì×í­Îßó©)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
YNS yellow nail syndrome
CREG Cross REactive Group (of HLA Antigens)
IRC International Red Cross
ANRC American National Red Cross
ARC accelerating rate calorimetry; acquired immunodeficiency syndrome-related complex; active renin conc...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CP-MAS Cross Polarisation Magic Angle Spinning
CRD Cross Reacting Determinant
CSA Cross sectional areas
CCF Cross-correlation functions
CCH Cross-correlation histograms
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • blue cross
    û½ÊÀÚ
  • cross
    ±³Â÷, ±³¹è, ±³Àâ
    ½ÊÀÚÀÇ Çüųª ±¸Á¶. ±³¹è¿¡ ÀÇÇØ ¸¸µé¾îÁø »ý¹°. ±³¹è ¹æ¹ý.
  • cross adaptation
    ±³Â÷ ¼øÀÀ
  • cross arch bar splint
    ¾Ç±³´ë ¿¬°á °íÁ¤ ÀåÄ¡
  • cross arch stabilization
    Ⱥ´ç Ä¡¿­±Ã ¾ÈÁ¤
  • cross bite occlusion
    ±³Â÷ ±³ÇÕ
  • cross contamination
    ±³Â÷ ¿À¿°
  • cross fire technique
    ½ÊÀÚÆ÷È­ Á¶»ç¹ý
  • cross heredity
    ±³Â÷ À¯Àü, ±³Â÷¼º À¯Àü
  • cross incision
    ½ÊÀÚ Àý°³
  • cross leg flap
    ÇÏÅð ±³Â÷ ÇÇÆÇ
  • cross linkage
    °¡±³È­
  • cross linking agent
    °¡±³Á¦
    ¼±»ó °íºÐÀÚÀÇ ºÐÀÚ°£À» È­ÇÐÀûÀ¸·Î °áÇÕÇϰí, ±×¹° ±¸Á¶¸¦ ¸¸µå´Â ÀÛ¿ëÀ» °®´Â ¹°Áú.
  • cross matching
    ±³Â÷ ½ÃÇè, ±³Â÷ ÀûÇÕ ½ÃÇè, ±³Â÷ ½ÃÇè¹ý, ±³Â÷ ÀûÇÕ ½ÃÇè¹ý
  • cross polymerization
    ±³Â÷ ÁßÇÕ
    ¼±»ó ÁßÇÕü ºÐÀÚ »çÀÌÀÇ È­ÇÐ °áÇÕ Çü¼ºÀº ±× ºÐÀÚµé·Î½á µÈ ¹«ÇÑ´ëÀÇ »ïÂ÷¿øÀû ¸Á»ó ±¸Á¶¿¡±îÁö À̸¦ ¼ö ÀÖ´Â ÁßÇÕ ¹ÝÀÀÀÌ´Ù. ±×·¡¼­ Àç·áÀÇ ¿ëÇØµµ, °­µµ, Èí¼ö¼ºÀ» ¹Ù²Ù´Â ÀÔüÀûÀÎ ¸Á»ó ±¸Á¶¸¦ Çü¼ºÇÏ°Ô µÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
cross-eye Alternative spelling for crossed eyes.
(05 Mar 2000)
cross flap A skin flap transferred from one part of the body to a corresponding part, as from one arm to the other.
(05 Mar 2000)
cross-hybridisation <molecular biology> The hydrogen bonding of asingle-stranded DNA sequence that is partially but not entirely complementary to a single-stranded substrate. Often, this involves hybridising a DNA probe for a specific DNA sequence to the homologous sequences of different species.
(09 Oct 1997)
cross hybridization Annealing of a DNA probe to an imperfectly matching DNA molecule.
(05 Mar 2000)
cross infection <microbiology> Infection transmitted between individuals infected with different pathogenic microorganisms. Any infection which a patient contracts in a health-care institution.
(12 Dec 1998)
cross-link A covalent linkage between two polymers or between two different regions of the same polymer.
(05 Mar 2000)
cross linking 1. <chemistry> The linking of the chains of a polymer to one another so that the polymer, as a network, becomes stronger and more resistant to being dissolved.
2. <molecular biology> The abnormal linking of two strands of DNA by covalent bonds (as opposed to the normal hydrogen bonds between base pairs), which can occur by exposure to X-rays. Such linking is a type of damage to the DNA molecule and must be repaired before the DNA can replicate and function properly again.
(09 Oct 1997)
cross-linking reagent <chemistry> Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other.
(12 Dec 1998)
cross-matching 1. A test for incompatibility between donor and recipient blood, carried out prior to transfusion to avoid potentially lethal haemolytic reactions between the donor's red blood cells and antibodies in the recipient's plasma, or the reverse; performed by mixing a sample of red blood cells of the donor with plasma of the recipient (major crossmatch) and the red blood cells of the recipient with the plasma of the donor (minor crossmatch). Incompatibility is indicated by clumping of red blood cells and contraindicates use of the donor's blood.
2. In allotransplantation of solid organs (e.g., kidney), a test for identification of antibody in the serum of potential allograft recipients which reacts directly with the lymphocytes or other cells of a potential allograft donor; presence of these antibodies usually, if not always, contraindicates the performance of the transplantation because virtually all such grafts will be subject to a hyperacute type of rejection.
(05 Mar 2000)
cross-pollination <botany> Fertilization of a plant from a plant with a different genetic makeup.
(09 Oct 1997)
cross-reacting agglutinin An immune agglutinin specific for a group antigen.
Synonym: cross-reacting agglutinin.
(05 Mar 2000)
cross-reacting antibody <immunology> Antibody specific for group antigens, i.e., those with identical functional groups, antibody for antigens that have functional groups of closely similar, but not identical, chemical structure.
(05 Mar 2000)
cross-reacting material <haematology> A substance sufficiently different from a reference substance (R) to have a perceptibly different function from R but sufficiently similar to R that it reacts with anti-R antibodies; e.g., mutant factor VIII may be defective or even inert in coagulation and yet be immunologically identified as factor VIII.
(05 Mar 2000)
cross reaction <haematology, immunology> Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
(12 Dec 1998)
cross-reactive antibody <haematology, immunology> Antibodies which don't respond to any one specific antigen, but will respond to a number of them. These antibodies can be responsible for false positive results in antigen-antibody tests.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cross-bar
    °¡·ÎÀå
  • cross-country
    µéÆÇÀ» °¡·ÎÁö¸£´Â
  • cross-examination
    ¹Ý´ë ½É¹®
  • cross-examine
    ¿¡ ¹Ý´ë ½É¹®ÇÏ´Ù
  • cross-eyed
    »çÆÈ¶ß±â
  • cross-grained
    °áÀÌ ºÒ±ÔÄ¢ÇÑ
  • cross-purpose
    ¹Ý´ëÀÇ ¸ñÀû
  • cross-question
    ¹Ý´ë ½É¹®
  • Celtic cross
    ÄÌÆ® ½ÊÀÚ°¡(Á߽ɿ¡ ringÀÌ ÀÖÀ½)
  • Charing Cross
    丵 Å©·Î½º(·±´ø½ÃÀÇ Áß¾Ó,Strand°¡ ¼­ÂÊ ³¡ÀÇ ¹øÈ­ ±¸¿ª)
  • Geneva cross
    Àû½ÊÀÚ
  • George Cross
    Á¶Áö ÈÆÀå(George 4¼¼¶§ Á¦Á¤ 1943)
  • Greek cross
    ±×¸®½º ½ÊÀÚ°¡
  • Green Cross Code
    ±¹¹Î Çлý¿ë ±³Åë ¾ÈÀü ±ÔÄ¢
  • Holy Cross Day
    ¼º ½ÊÀÚ°¡ Âù¹ÌÀÇ ³¯(9¿ù 14ÀÏ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á